Under exceptional circumstances, individual donations from donors who do not comply with the following criteria may be authorised by a qualified healthcare professional in the blood establishment. All such cases must be clearly documented and subject to the quality management provisions in Articles 11, 12, and 13 of Directive 2002/98/EC.
The following criteria do not apply to autologous donations.
Age | 18 to 65 years |
17 to 18 years |
unless classified as a minor by law, or with written consent of parent or legal guardian in accordance with law
First time donors over 60 years |
at the discretion of the physician in the blood establishment
Over 65 years |
with permission of the physician in the blood establishment, given annually
Body weight | ≥ 50 kg for donors either of whole blood or apheresis blood components
Haemoglobin |
for females
≥ 125 g/l
for males
≥ 135 g/l
Applicable to allogeneic donors of whole blood and cellular components
Protein | ≥ 60 g/l | The protein analysis for apheresis plasma donations must be performed at least annually
Platelets | Platelet number greater than or equal to 150 × 109/l | Level required for apheresis platelet donors
The tests and deferral periods indicated by an asterisk (*) are not required when the donation is used exclusively for plasma for fractionation.
Cardiovascular disease | Prospective donors with active or past serious cardiovascular disease, except congenital abnormalities with complete cure
Central nervous system disease | A history of serious CNS disease
Abnormal bleeding tendency | Prospective donors who give a history of a coagulopathy
Repeated episodes of syncope, or a history of convulsions | Other than childhood convulsions or where at least three years have elapsed since the date the donor last took anticonvulsant medication without any recurrence of convulsions
Gastrointestinal, genitourinary, haematological, immunological, metabolic, renal, or respiratory system diseases | Prospective donors with serious active, chronic, or relapsing disease
Diabetes | If being treated with insulin
Infectious diseases | Hepatitis B, except for HBsAg-negative persons who are demonstrated to be immune
Hepatitis C
HIV-1/2
HTLV I/II
Babesiosis (*)
Kala Azar (visceral leishmaniasis) (*)
Trypanosomiasis cruzi (Chagas' disease) (*)
Malignant diseases | Except in situ cancer with complete recovery
Transmissible spongiform encephalopathies (TSEs), (e.g. Creutzfeldt Jakob Disease, variant Creutzfeldt Jakob Disease) | Persons who have a family history which places them at risk of developing a TSE, or persons who have received a corneal or dura mater graft, or who have been treated in the past with medicines made from human pituitary glands. For variant Creutzfeldt Jacob disease, further precautionary measures may be recommended.
Intravenous (IV) or intramuscular (IM) drug use | Any history of non-prescribed IV or IM drug use, including body-building steroids or hormones
Xenotransplant recipients |
Sexual behaviour | Persons whose sexual behaviour puts them at high risk of acquiring severe infectious diseases that can be transmitted by blood
After an infectious illness, prospective donors shall be deferred for at least two weeks following the date of full clinical recovery.
However, the following deferral periods shall apply for the infections listed in the table:
Brucellosis (*) | 2 years following the date of full recovery
Osteomyelitis | 2 years after confirmed cured
Q fever (*) | 2 years following the date of confirmed cured
Syphilis (*) | 1 year following the date of confirmed cured
Toxoplasmosis (*) | 6 months following the date of clinical recovery
Tuberculosis | 2 years following the date of confirmed cured
Rheumatic fever | 2 years following the date of cessation of symptoms, unless evidence of chronic heart disease
Fever > °C | 2 weeks following the date of cessation of symptoms
Flu-like illness | 2 weeks after cessation of symptoms
Malaria (*)
individuals who have lived in a malarial area within the first five years of life
3 years following return from last visit to any endemic area, provided person remains symptom free;
may be reduced to 4 months if an immunologic or molecular genomic test is negative at each donation
individuals with a history of malaria
3 years following cessation of treatment and absence of symptoms.
Accept thereafter only if an immunologic or molecular genomic test is negative
asymptomatic visitors to endemic areas
6 months after leaving the endemic area unless an immunologic or molecular genomic test is negative
individuals with a history of undiagnosed febrile illness during or within six months of a visit to an endemic area
3 years following resolution of symptoms;
may be reduced to 4 months if an immunologic or molecular test is negative
West Nile Virus (WNV) (*) | 28 days after leaving a risk area of locally acquired West Nile Virus unless an individual Nucleic Acid Test (NAT) is negative
Endoscopic examination using flexible instruments,
mucosal splash with blood or needlestick injury,
transfusion of blood components,
tissue or cell transplant of human origin,
major surgery,
tattoo or body piercing,
acupuncture unless performed by a qualified practitioner and with sterile single-use needles,
persons at risk due to close household contact with persons with hepatitis B.
Defer for 6 months, or for 4 months provided a NAT test for hepatitis C is negative
Persons whose behaviour or activity places them at risk of acquiring infectious diseases that may be transmitted by blood. | Defer after cessation of risk behaviour for a period determined by the disease in question, and by the availability of appropriate tests
Attenuated viruses or bacteria | 4 weeks
Inactivated/killed viruses, bacteria or rickettsiae | No deferral if well
Toxoids | No deferral if well
Hepatitis A or hepatitis B vaccines | No deferral if well and if no exposure
Rabies |
No deferral if well and if no exposure
If vaccination is given following exposure defer for one year
Tick-borne encephalitis vaccines | No deferral if well and if no exposure
Pregnancy | 6 months after delivery or termination, except in exceptional circumstances and at the discretion of a physician
Minor surgery | 1 week
Dental treatment |
Minor treatment by dentist or dental hygienist — defer until next day
(NB: Tooth extraction, root-filling and similar treatment is considered as minor surgery)
Medication | Based on the nature of the prescribed medicine, its mode of action and the disease being treated
Particular epidemiological situations (e.g. disease outbreaks) | Deferral consistent with the epidemiological situation (These deferrals should be notified by the competent authority to the European Commission with a view to Community action)
Serious cardiac disease | Depending on the clinical setting of the blood collection
Persons with or with a history of
hepatitis B, except for HBsAg-negative persons who are demonstrated to be immune
hepatitis C
HIV-1/2
HTLV I/II
Member States may, however, establish specific provisions for autologous donations by such persons
Active bacterial infection |